FDA issued a Warning Letter to Valeant Pharmacueticals International on 11/3/2016 as a result of this inspection.
483 Valeant Pharmacueticals North America Sep 2016

483 Valeant Pharmacueticals North America Sep 2016

Nicholas Mendiola FDA, Matthew Schnittker FDA$119.00 - Available Now

FDA investigators audited the Valeant Pharmacueticals North America - Rochester, NY, United States facility and issued 3 inspectional observations (via FDA 483) on 01 Sep 2016.

Product details

  • Category: Medical Devices & Rad Health
  • Number of Observations: 3
  • Inspection end: 01 Sep 2016
  • Location: Rochester, United States
  • FEI: 3009443653
Add To Cart